SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic

After 18 months of the COVID‐19 pandemic, data concerning SARS‐CoV‐2 infection in pregnant women and their neonates are progressively taking the place of complete uncertainty. Here, we summarize updated evidence regarding several critical aspects of perinatal SARS‐CoV‐2 infection, including 1) verti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietrasanta, Carlo, Artieri, Giacomo, Ronchi, Andrea, Crippa, Beatrice, Ballerini, Claudia, Crimi, Riccardo, Mosca, Fabio, Pugni, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305748/
https://www.ncbi.nlm.nih.gov/pubmed/35080307
http://dx.doi.org/10.1111/pai.13643
_version_ 1784752394674896896
author Pietrasanta, Carlo
Artieri, Giacomo
Ronchi, Andrea
Crippa, Beatrice
Ballerini, Claudia
Crimi, Riccardo
Mosca, Fabio
Pugni, Lorenza
author_facet Pietrasanta, Carlo
Artieri, Giacomo
Ronchi, Andrea
Crippa, Beatrice
Ballerini, Claudia
Crimi, Riccardo
Mosca, Fabio
Pugni, Lorenza
author_sort Pietrasanta, Carlo
collection PubMed
description After 18 months of the COVID‐19 pandemic, data concerning SARS‐CoV‐2 infection in pregnant women and their neonates are progressively taking the place of complete uncertainty. Here, we summarize updated evidence regarding several critical aspects of perinatal SARS‐CoV‐2 infection, including 1) vertical transmission of the virus in utero, which is possible but seems rare according to current epidemiological data; 2) how COVID‐19 during pregnancy can shape maternal and neonatal outcomes, either directly or indirectly; 3) how recommendations regarding the management of infected dyads have been progressively modified in light of new scientific evidence; and 4) how maternal infection or vaccination can induce the passive protection of fetuses and neonates against the infection, through the transfer of specific antibodies before and after birth.
format Online
Article
Text
id pubmed-9305748
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93057482022-07-28 SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic Pietrasanta, Carlo Artieri, Giacomo Ronchi, Andrea Crippa, Beatrice Ballerini, Claudia Crimi, Riccardo Mosca, Fabio Pugni, Lorenza Pediatr Allergy Immunol Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology After 18 months of the COVID‐19 pandemic, data concerning SARS‐CoV‐2 infection in pregnant women and their neonates are progressively taking the place of complete uncertainty. Here, we summarize updated evidence regarding several critical aspects of perinatal SARS‐CoV‐2 infection, including 1) vertical transmission of the virus in utero, which is possible but seems rare according to current epidemiological data; 2) how COVID‐19 during pregnancy can shape maternal and neonatal outcomes, either directly or indirectly; 3) how recommendations regarding the management of infected dyads have been progressively modified in light of new scientific evidence; and 4) how maternal infection or vaccination can induce the passive protection of fetuses and neonates against the infection, through the transfer of specific antibodies before and after birth. John Wiley and Sons Inc. 2022-01-25 2022-01 /pmc/articles/PMC9305748/ /pubmed/35080307 http://dx.doi.org/10.1111/pai.13643 Text en © 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology
Pietrasanta, Carlo
Artieri, Giacomo
Ronchi, Andrea
Crippa, Beatrice
Ballerini, Claudia
Crimi, Riccardo
Mosca, Fabio
Pugni, Lorenza
SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title_full SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title_fullStr SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title_full_unstemmed SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title_short SARS‐CoV‐2 infection and neonates: Evidence‐based data after 18 months of the pandemic
title_sort sars‐cov‐2 infection and neonates: evidence‐based data after 18 months of the pandemic
topic Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305748/
https://www.ncbi.nlm.nih.gov/pubmed/35080307
http://dx.doi.org/10.1111/pai.13643
work_keys_str_mv AT pietrasantacarlo sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT artierigiacomo sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT ronchiandrea sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT crippabeatrice sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT balleriniclaudia sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT crimiriccardo sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT moscafabio sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic
AT pugnilorenza sarscov2infectionandneonatesevidencebaseddataafter18monthsofthepandemic

Ejemplares similares